Skip to main content

Table 2 Clinical characteristics among the studied groups

From: Helicobacter pylori infection in patients with metabolic syndrome, with or without nonalcoholic fatty liver disease

 

Total N = 300

Control N = 100

Metabolic with NAFLD N = 100

Metabolic without NAFLD N = 100

Test of significance

Within group significance

Weight (kg)

83.22 ± 17.63

74.35 ± 9.46

95.80 ± 23.41

79.51 ± 6.93

F = 54.86

P < 0.001*

p1 < 0.001*

p2 = 0.016*

p3 < 0.001*

Height (cm)

170.21 ± 10.94

171.92 ± 8.94

169.87 ± 13.47

168.84 ± 9.75

F = 2.07

P = 0.13

p1 = 0.18

p2 = 0.04*

p3 = 0.50

BMI (kg/m2)

28.91 ± 7.04

25.28 ± 3.08

33.18 ± 10.03

28.28 ± 2.74

F = 40.49

P < 0.001*

p1 < 0.001*

p2 < 0.001*

p3 = 0.001*

Waist circumference (cm)

100.73 ± 13.40

118.40 ± 16.27

102.15 ± 10.51

107.09 ± 15.75

F = 52.12

P < 0.001*

p1 < 0.001*

p2 = 0.46

p3 = 0.001*

Systolic blood pressure (mmHg)

129.77 ± 22.64

114.6 ± 15.0

133.90 ± 25.30

140.80 ± 17.6

F = 47.06

P < 0.001*

p1 < 0.001*

p2 < 0.001*

p3 = 0.01*

Diastolic blood pressure (mmHg)

82.17 ± 9.48

75.0 ± 8.34

84.60 ± 8.09

86.90 ± 7.48

F = 62.54

P < 0.001*

p1 < 0.001*

p2 < 0.001*

p3 = 0.04*

  1. *statistically significant value
  2. F one way ANOVA test, χ2 Chi-square test, all parameters described as mean ± SD, number and percentage, p1 difference between control and metabolic with NAFLD group, p2 difference between control and metabolic without NAFLD group, p3 difference between metabolic with and without NAFLD